Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections
出版年份 2016 全文链接
标题
Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections
作者
关键词
-
出版物
Future Microbiology
Volume 11, Issue 9, Pages 1179-1189
出版商
Future Medicine Ltd
发表日期
2016-08-22
DOI
10.2217/fmb-2016-0064
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Understanding the mechanisms and drivers of antimicrobial resistance
- (2016) Alison H Holmes et al. LANCET
- Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer
- (2016) Christian J. H. von Wintersdorff et al. Frontiers in Microbiology
- Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection
- (2015) Charlesnika T. Evans et al. CLINICAL INFECTIOUS DISEASES
- Combatting bacterial infections by killing persister cells with mitomycin C
- (2015) Brian W. Kwan et al. ENVIRONMENTAL MICROBIOLOGY
- Clostridium difficilerecurrent infection: possible implication of TA systems
- (2015) Fernando Gil et al. Future Microbiology
- Staphylococcus aureuschronic and relapsing infections: Evidence of a role for persister cells
- (2014) Brian P. Conlon BIOESSAYS
- Clostridium difficilespores: a major threat to the hospital environment
- (2014) Jonathan Barra-Carrasco et al. Future Microbiology
- Total Synthesis and Antibacterial Testing of the A54556 Cyclic Acyldepsipeptides Isolated from Streptomyces hawaiiensis
- (2014) Jordan D. Goodreid et al. JOURNAL OF NATURAL PRODUCTS
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
- (2014) Charlie G. Buffie et al. NATURE
- Spore Formation and Toxin Production in Clostridium difficile Biofilms
- (2014) Ekaterina G. Semenyuk et al. PLoS One
- Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
- (2014) Casey M. Theriot et al. Nature Communications
- A new strategy to fight antimicrobial resistance: the revival of old antibiotics
- (2014) Nadim Cassir et al. Frontiers in Microbiology
- Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets
- (2013) David M Roberts et al. Future Microbiology
- The ClpP peptidase of Wolbachia endobacteria is a novel target for drug development against filarial infections
- (2013) Andrea Schiefer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Community-associated Clostridium difficile infection and antibiotics: a meta-analysis
- (2013) Abhishek Deshpande et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activation of ClpP Protease by ADEP Antibiotics: Insights from Hydrogen Exchange Mass Spectrometry
- (2013) Modupeola A. Sowole et al. JOURNAL OF MOLECULAR BIOLOGY
- Activated ClpP kills persisters and eradicates a chronic biofilm infection
- (2013) B. P. Conlon et al. NATURE
- Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species
- (2013) I. Keren et al. SCIENCE
- Genome-Wide Analysis of Cell Type-Specific Gene Transcription during Spore Formation in Clostridium difficile
- (2013) Laure Saujet et al. PLoS Genetics
- Global Analysis of the Sporulation Pathway of Clostridium difficile
- (2013) Kelly A. Fimlaid et al. PLoS Genetics
- Targeting Persisters for Tuberculosis Control
- (2012) Ying Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The active ClpP protease fromM. tuberculosisis a complex composed of a heptameric ClpP1 and a ClpP2 ring
- (2012) Tatos Akopian et al. EMBO JOURNAL
- TheClostridium difficile spo0AGene Is a Persistence and Transmission Factor
- (2012) Laura J. Deakin et al. INFECTION AND IMMUNITY
- ClpP: A structurally dynamic protease regulated by AAA+ proteins
- (2012) John A. Alexopoulos et al. JOURNAL OF STRUCTURAL BIOLOGY
- Clostridium difficile Spore-Macrophage Interactions: Spore Survival
- (2012) Daniel Paredes-Sabja et al. PLoS One
- Informe: infecciones por Clostridium difficile en el Hospital de Urgencia Asistencia Pública (HUAP) Dr. Alejandro del Río de Santiago, Chile
- (2012) Revista Chilena de Infectologia
- Mycobacterium tuberculosis ClpP1 and ClpP2 Function Together in Protein Degradation and Are Required for Viability in vitro and During Infection
- (2012) Ravikiran M. Raju et al. PLoS Pathogens
- Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
- (2012) Trevor D. Lawley et al. PLoS Pathogens
- Novel Pentadecenyl Tetrazole Enhances Susceptibility of Methicillin-ResistantStaphylococcus aureusBiofilms to Gentamicin
- (2011) Krista M. Olson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Methylation Effect in Medicinal Chemistry
- (2011) Eliezer J. Barreiro et al. CHEMICAL REVIEWS
- Chemical Activators of ClpP: Turning Jekyll into Hyde
- (2011) David A. Dougan CHEMISTRY & BIOLOGY
- Validation of the Essential ClpP Protease in Mycobacterium tuberculosis as a Novel Drug Target
- (2011) J. Ollinger et al. JOURNAL OF BACTERIOLOGY
- Acyl depsipeptide (ADEP) resistance in Streptomyces
- (2011) M. Gominet et al. MICROBIOLOGY-SGM
- Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ
- (2011) P. Sass et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Persister Cells
- (2010) Kim Lewis Annual Review of Microbiology
- Acyldepsipeptide Antibiotics Induce the Formation of a Structured Axial Channel in ClpP: A Model for the ClpX/ClpA-Bound State of ClpP
- (2010) Dominic Him Shun Li et al. CHEMISTRY & BIOLOGY
- Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism
- (2010) Byung-Gil Lee et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Efflux-Mediated Drug Resistance in Bacteria
- (2009) Xian-Zhi Li et al. DRUGS
- The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease
- (2009) Janine Kirstein et al. EMBO Molecular Medicine
- Temporal effects of antibiotic use and Clostridium difficile infections
- (2009) Nathalie Vernaz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clostridium difficile— More Difficult Than Ever
- (2008) Ciarán P. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now